Article
Plasma proteomics identifies CRTAC1 as a biomarker for osteoarthritis severity and progression
4 Aug 2022
Abstract excerpt
OBJECTIVES: The aim of this study was to identify biomarkers for radiographic OA severity and progression acting within the inflammation and metabolic pathways. METHODS: For 3517 Rotterdam Study participants, 184 plasma protein levels were measured using Olink inflammation and cardiometabolic panels. We studied associations with severity and progression of knee, hip and hand OA and a composite overall OA burden...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
